SNM nets AHRQ grant for comparative effectiveness

SNM (formerly the Society of Nuclear Medicine) has been awarded a $48,000 grant from the Agency for Healthcare Research and Quality (AHRQ) to hold a conference to develop research on the comparative effectiveness of PET and other molecular imaging techniques.

The primary emphasis of the conference will be on the diagnosis and management of cancer patients, but both cardiology and neurology questions will also be addressed, said SNM.

With the grant from AHRQ, SNM will host the workshop, "Comparative Effectiveness in Molecular Imaging," July 21–22, in the Washington, D.C. area. The two-day workshop will review the current information on molecular imaging, current healthcare costs and how clinical and cost effectiveness research can be a valuable method of addressing all of these issues for managing the treatment and care of cancer patients in today’s healthcare environment, said the Reston, Va.-based organization.

Around the web

The new technology shows early potential to make a significant impact on imaging workflows and patient care. 

Richard Heller III, MD, RSNA board member and senior VP of policy at Radiology Partners, offers an overview of policies in Congress that are directly impacting imaging.
 

The two companies aim to improve patient access to high-quality MRI scans by combining their artificial intelligence capabilities.